Targeting DXP synthase in bacterial metabolism

靶向细菌代谢中的 DXP 合酶

• 批准号: 10576858
• 负责人: Caren L. Freel Meyers
• 金额: $ 57.62万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-03-15 至 2026-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10576858
• 关键词: Address; Anabolism; Anti-Bacterial Agents; Antibiotics; Antimicrobial Resistance; Bacteria; Cell physiology; Clinical; Combined Modality Therapy; Development; Diphosphates; Drug Kinetics; Drug Targeting; Drug resistance; Environment; Enzymatic Biochemistry; Enzymes; Goals; Growth; Human; Immune response; Infection; Learning; Metabolic; Metabolic Pathway; Metabolism; Modeling; Mus; Nutrient; Nutritional; Outcome; Pathogenicity; Pathway interactions; Permeability; Positioning Attribute; Predisposition; Prevalence; Prodrugs; Public Health; Pyridoxal Phosphate; Reaction; Research; Resistance; Role; Serine; Stress; Structure; Testing; Thiamine; Urinary tract; Urinary tract infection; Uropathogen; Vitamins; Work; analog; antibiotic resistant infections; antimicrobial; ascending urinary tract infection; bacterial metabolism; combat; design; efficacy evaluation; efficacy study; efficacy testing; feeding; in vivo; inhibitor; inorganic phosphate; isoprenoid; mutant; pathogen; pathogenic bacteria; prevent; priority pathogen; synergism; targeted agent; targeted treatment; uptake; xylulose-5-phosphate

There is an urgent need to develop new antimicrobial strategies to combat the increasing occurrence of drug resistance in clinical pathogens. Current antibiotics act on a limited set of cellular processes, and the rate of new inhibitor discovery is rapidly declining. With the diminishing arsenal of useful antibiotics, other essential cellular processes must be explored as antibacterial targets. During infection, bacterial pathogens rapidly respond to changes in the host microenvironment by remodeling metabolism to promote growth. These “metabolic adaptations” are crucial for pathogen survival and pathogenicity in vivo and are thus a promising target space for antibiotic development. Positioned at a metabolic branch point to supply essential vitamins and isoprenoids, 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) is poised to be a key player in bacterial metabolic adaptation during infection, thus it is a potential target. We have uncovered several unique features of DXPS structure and mechanism that have guided the development of selective inhibitors that exert antibacterial activity by a mechanism involving DXPS inhibition. Our research will test the hypothesis that inhibition of DXPS will severely hinder pathogen metabolic adaptation in the host and take the next steps to develop antibacterial strategies targeting DXPS in clinical pathogens.

迫切需要开发新的抗菌策略来对抗临床病原体中日益增加的耐药性，目前的抗生素作用于有限的细胞过程，并且随着有用的抗生素库的减少，新抑制剂的发现率正在迅速下降。在感染过程中，细菌病原体通过重塑新陈代谢以促进生长来快速响应宿主微环境的变化，这些“代谢适应”对于病原体的生存和致病性至关重要。 1-脱氧-D-木酮糖 5-磷酸合酶 (DXPS) 位于提供必需维生素和类异戊二烯的代谢分支点，因此是抗生素开发的一个有前景的目标空间，有望成为细菌代谢的关键参与者。因此，我们发现了 DXPS 结构和机制的几个独特特征，这些特征指导了通过涉及 DXPS 抑制的机制发挥抗菌活性的选择性抑制剂的开发。将测试抑制 DXPS 将严重阻碍宿主病原体代谢适应的假设，并采取下一步措施开发针对临床病原体中 DXPS 的抗菌策略。